This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Innovations of Sheng-Ping Wang in Diabetes Treatment
Introduction
Sheng-Ping Wang is a notable inventor based in Annandale, NJ (US). He has made significant contributions to the field of diabetes treatment through his innovative research and patenting efforts. His work focuses on the development of methods that can potentially improve the lives of those affected by diabetes.
Latest Patents
Sheng-Ping Wang holds a patent for "Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor." This patent discloses the use of a glucagon receptor antagonist in conjunction with a cholesterol absorption inhibitor for the treatment of diabetes and related conditions. His innovative approach aims to provide new therapeutic options for managing diabetes effectively.
Career Highlights
Wang is associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His role at Merck has allowed him to collaborate with other experts in the field, enhancing the impact of his research on diabetes treatment.
Collaborations
Some of his notable coworkers include Hong-Ping Guan and Jose M Castro-Perez. Their collaborative efforts contribute to the advancement of research and development in diabetes therapies.
Conclusion
Sheng-Ping Wang's innovative work in diabetes treatment exemplifies the importance of research and patenting in the medical field. His contributions have the potential to change the landscape of diabetes management and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile